TANFAC Industries reported a strong Q2 FY27, with revenue rising to Rs 230.48 crore from Rs 168.69 crore last year. Quarterly net profit increased to Rs 19.03 crore, even as the half-year profit faced a marginal decline. The company is currently executing a Rs 495 crore expansion for a fluorinated product plant, which remains a key focus for shareholders monitoring long-term growth.
TANFAC Industries Reports Strong Q2 Revenue Growth
Revenue from operations reached Rs 230.48 crore for Q2 FY27.
Net profit for the same period stood at Rs 19.03 crore.
Reader Takeaway: Robust top-line growth driven by chemical operations, though half-year profitability faces slight pressure from rising costs.
What just happened
TANFAC Industries Ltd released its financial results for the quarter and half-year ended September 30, 2026. The company reported a significant increase in revenue, climbing to Rs 230.48 crore for the September quarter compared to Rs 168.69 crore in the same period last year. Net profit for the quarter also saw growth, rising to Rs 19.03 crore from Rs 17.18 crore year-on-year.
Why this matters
For the half-year period, revenue grew to Rs 417.66 crore from Rs 344.69 crore. However, net profit for the six-month period softened slightly to Rs 35.88 crore, compared to Rs 36.53 crore in the corresponding period of the previous year. This indicates that while sales volume is expanding, operational margins are under slight observation.
Business and Capex Update
The company operates as a single-segment entity focused on the chemicals business. Management confirmed that the construction of its new 20,000 MTPA downstream fluorinated product plant is progressing. This ambitious project involves a capital expenditure of Rs 495 crore, which is expected to be a major driver for the company's future production capacity.
Governance and Audit
The Board of Directors approved these financial results on November 2, 2026, following a review by the Audit Committee. The company's statutory auditors, Ramasamy Koteswara Rao and Co LLP, provided an unmodified review report, confirming that the financial statements were prepared according to standard practices.
What to track next
Investors should closely track the commissioning timeline of the new fluorinated product facility. The successful execution of this Rs 495 crore project is vital for scaling revenue further and potentially improving profitability margins in the coming fiscal years.